APLS

APELLIS PHARMACEUTICALS INC

Healthcare | Mid Cap

-$0.39

EPS Forecast

$204.9

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Market expectations

EPS Expectation:

-$0.39

Revenue Expectation:

$204.9

EPS Surprise Expectation:

-$0.004

Revenue Surprise Expectation:

$4

Post-release price volatility - Very high

Post-release Overnight Move:

±10.2%

Post-release 1-week Move:

±

Expected price impact

If company results match EPS & revs consensus exactly:

-0.2%

If company results match Proximilar expectations exactly:

0.7%

Earnings volatility

EPS standard deviation:

$0.24

Revenue standard deviation:

$16

As % of share price:

1.35% VERY HIGH

As % of market cap:

0.71% MEDIUM